Mazhed Kheyrbek
Cardiovascular Disease · Detroit, MINPI 1134790009
Payments from drug & device makers
Across 85 payments — averaging $74.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$1K
- Kestra Medical Technology Services, Inc.$1K
- Boehringer Ingelheim$441
- Teleflex LLC$340
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$228
- plus $1K from 14 others
What the payments were for
- Consulting fees$501%
- Speaking & faculty fees$721%
- Travel & lodging$1,86529%
- Food & beverage$4,12865%
- Education$2244%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $1,851 |
| Boston Scientific | 8 | $1,192 |
| Kestra Medical Technology Services, Inc. | 20 | $1,104 |
| Boehringer Ingelheim | 4 | $441 |
| Teleflex LLC | 6 | $340 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $228 |
| Medtronic | 4 | $181 |
| Cardiva Medical, Inc. | 2 | $147 |
| Amgen | 1 | $126 |
| Bayer | 1 | $125 |
| Chiesi USA, Inc. | 7 | $115 |
| Penumbra, Inc. | 1 | $103 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $92 |
| BD | 2 | $72 |
| Abiomed | 1 | $51 |
| Biotronik Inc. | 1 | $50 |
| Biosense Webster, Inc. | 1 | $44 |
| Johnson & Johnson | 2 | $33 |
| Shockwave Medical, Inc | 1 | $26 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$884
- GALLANT$679
- MERLIN@HOME$606
- Assure WCD$569
- JARDIANCE$357
- WATCHMAN FLX$250
- ENSITE$135
- TURNPIKE$132
- GUIDELINER$126
- Repatha$126
- Kerendia$125
- Cardiva VASCADE MVP VVCS 6-12F$121
- Indigo System$103
How this compares
$6,339 in reported general payments places this provider in the 60th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 12 | $122 |
| Carvedilol | 11 | $120 |
| Atorvastatin Calcium | 15 | $119 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Detroit
- Brian OneillDetroit$1.4M
- Pedro Villablanca SpinettoDetroit$844K
- Khaled Abdul NourDetroit$735K
- David LanfearDetroit$719K
- Gerald KoenigDetroit$612K
- Mouaz Al-MallahDetroit$475K
- Sachin ParikhDetroit$458K
- Karthikeyan AnanthasubramaniamDetroit$355K
- Pedro Engel GonzalezDetroit$345K
- Wayne WeaverDetroit$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.